Compare of Surgical Condition and Complications With Moderate and Deep NM Block

• Status: Unknown status
• Trial end date: 2017-08-01
• Target enrollment: 0
• Participant gender: All

Summary

This study is designed to evaluate the surgeon's satisfaction with either deep or moderate neuromuscular blockade during laparoscopic gastrectomy surgery and observe the recovery profiles in the recovery room and the ward.The explorative objective of this study is to evaluate the safety profiles of deep and moderate neuromuscular blockades via observation of postoperative complications.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Chonnam National University Hospital
• Treatments: Atracurium; Cisatracurium; Glycopyrrolate; Neuromuscular Blocking Agents; Rocuronium

Criteria

Inclusion Criteria:

• All adult (≥ 20 years of age) patients scheduled for an elective laparoscopic gastrectomy who have signed the written informed consent.

Exclusion Criteria:

• Known allergy to rocuronuim, cisatracurium or sugammadex

• Significant liver or kidney dysfunction

• Any neuromuscular disease

• Pregnant or breast feeding

• Indication for rapid sequence induction

• Inability to give informed consent

• Patients taking any medication with potential interference with neuromuscular transmission